Tratamiento de las infecciones producidas por micobacterias no tuberculosas

Tortoli, 2006, The new mycobacteria: An update, FEMS Immunol Med Microbiol., 48, 159, 10.1111/j.1574-695X.2006.00123.x Tortoli, 2014, Microbiological features and clinical relevance of new species of the genus Mycobacterium, Clin Microbiol Rev., 27, 727, 10.1128/CMR.00035-14 Lake, 2016, “Why me, why now?” Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection, BMC Med., 14, 54, 10.1186/s12916-016-0606-6 Wu, 2015, Host susceptibility to non-tuberculous mycobacterial infections, Lancet Infect Dis., 15, 968, 10.1016/S1473-3099(15)00089-4 Brown-Elliott, 2012, Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria, Clin Microbiol Rev., 25, 545, 10.1128/CMR.05030-11 Rose, 2014, Mycobacterium avium biofilm attenuates mononuclear phagocyte function by triggering hyperstimulation and apoptosis during early infection, Infect Immun., 82, 405, 10.1128/IAI.00820-13 Martin-de-Hijas, 2009, Biofilm development by clinical strains of non-pigmented rapidly growing mycobacteria, Clin Microbiol Infect., 15, 931, 10.1111/j.1469-0691.2009.02882.x Munoz-Egea, 2015, [In vitro susceptibility of rapidly growing mycobacteria biofilms against different antimicrobials], Enferm Infecc Microbiol Clin., 33, 136 Esteban, 2012, Current treatment of nontuberculous mycobacteriosis: an update, Expert Opin Pharmacother., 13, 967, 10.1517/14656566.2012.677824 Fennelly, 2016, Biofilm formation by Mycobacterium abscessus in a lung cavity, Am J Respir Crit Care Med., 193, 692, 10.1164/rccm.201508-1586IM Munoz-Egea, 2016, Effect of antibiotics and antibiofilm agents in the ultrastructure and development of biofilms developed by nonpigmented rapidly growing mycobacteria, Microb Drug Resist., 22, 1, 10.1089/mdr.2015.0124 Boyle, 2015, Comparison of clinical features. virulence, and relapse among Mycobacterium avium complex species, Am J Respir Crit Care Med., 191, 1310, 10.1164/rccm.201501-0067OC Zimmermann, 2015, The management of non-tuberculous cervicofacial lymphadenitis in children: A systematic review and meta-analysis, J Infect., 71, 9, 10.1016/j.jinf.2015.02.010 Wallace, 2014, Macrolide/Azalide therapy for nodular/bronchiectatic Mycobacterium avium complex lung disease, Chest., 146, 276, 10.1378/chest.13-2538 Chaisson, 1997, Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection, AIDS., 11, 311, 10.1097/00002030-199703110-00008 Griffith, 2007, An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases, Am J Respir Crit Care Med., 175, 367, 10.1164/rccm.200604-571ST Wallace, 2002, Repeat positive cultures in Mycobacterium intracellulare lung disease after macrolide therapy represent new infections in patients with nodular bronchiectasis, J Infect Dis., 186, 266, 10.1086/341207 Shitrit, 2008, Clinical and radiological features of Mycobacterium kansasii infection and Mycobacterium simiae infection, Respir Med., 102, 1598, 10.1016/j.rmed.2008.05.004 Philley, 2015, Treatment of slowly growing mycobacteria, Clin Chest Med., 36, 79, 10.1016/j.ccm.2014.10.005 Hoefsloot, 2008, The rising incidence and clinical relevance of Mycobacterium malmoense: A review of the literature, Int J Tuberc Lung Dis., 12, 987 Tortoli, 1998, Pulmonary infection due to Mycobacterium szulgai, case report and review of the literature, Eur Respir J., 11, 975, 10.1183/09031936.98.11040975 Nienhuis, 2010, Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: A randomised controlled trial, Lancet., 375, 664, 10.1016/S0140-6736(09)61962-0 Brown-Elliott, 2017, Rapidly growing mycobacteria, Microbiol Spectr., 5, 10.1128/microbiolspec.TNMI7-0027-2016 Esteban, 2000, [Rapidly growing mycobacteria in human pathology], Enferm Infecc Microbiol Clin., 18, 279 Wallace, 1989, The clinical presentation, diagnosis, and therapy of cutaneous and pulmonary infections due to the rapidly growing mycobacteria, M.fortuitum and M.chelonae, Clin Chest Med., 10, 419, 10.1016/S0272-5231(21)00644-4 Wallace, 1983, Spectrum of disease due to rapidly growing mycobacteria, Rev Infect Dis., 5, 657, 10.1093/clinids/5.4.657 Esteban, 2008, Epidemiology of infections due to nonpigmented rapidly growing mycobacteria diagnosed in an urban area, Eur J Clin Microbiol Infect Dis., 27, 951, 10.1007/s10096-008-0521-7 Bryant, 2016, Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium, Science., 354, 751, 10.1126/science.aaf8156 Alcaide, 2010, [Cutaneous and soft skin infections due to non-tuberculous mycobacteria], Enferm Infecc Microbiol Clin., 28, 46, 10.1016/S0213-005X(10)70008-2 Alcaide, 2017, [Methods for determining the antimicrobial susceptibility of mycobacteria], Enferm Infecc Microbiol Clin., 35, 529, 10.1016/j.eimc.2016.04.008 Esteban, 2009, Current treatment of atypical mycobacteriosis, Expert Opin Pharmacother., 10, 2787, 10.1517/14656560903369363 Choi, 2017, Clinical characteristics and treatment outcomes of patients with acquired macrolide-resistant Mycobacterium abscessus lung disease, Antimicrob Agents Chemother., 61, 10.1128/AAC.01146-17 Candido, 2014, Multidrug-resistant nontuberculous mycobacteria isolated from cystic fibrosis patients, J Clin Microbiol., 52, 2990, 10.1128/JCM.00549-14 El Helou, 2013, Rapidly growing mycobacterial bloodstream infections, Lancet Infect Dis., 13, 166, 10.1016/S1473-3099(12)70316-X Eid, 2007, Prosthetic joint infection due to rapidly growing mycobacteria: Report of 8 cases and review of the literature, Clin Infect Dis., 45, 687, 10.1086/520982 Gnanenthiran, 2017, Prosthetic valve infective endocarditis with Mycobacterium fortuitum: Antibiotics alone can be curative, Heart Lung Circ., 26, e86, 10.1016/j.hlc.2017.05.135 Vail, 2000, Successful treatment of Mycobacterium fortuitum prosthetic valve endocarditis: Case report, Clin Infect Dis., 30, 629, 10.1086/313720 Aubry, 2017, Mycobacterium marinum, Microbiol Spectr., 5., 10.1128/microbiolspec.TNMI7-0038-2016 Aubry, 2000, Antibiotic susceptibility pattern of Mycobacterium marinum, Antimicrob Agents Chemother., 44, 3133, 10.1128/AAC.44.11.3133-3136.2000